A World Health Organization (WHO)-commissioned systematic review published in Environment International finds no association ...

Madison LeCroy knows the importance of a healthy work-life balance.

Glucagon-like peptide 1 receptor agonist use is not associated with an increased risk for thyroid cancer over the short term.

Thyroid cancer is a disease in which malignant (cancer) cells form in the tissues of the thyroid gland. In 2020, there were ...

On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...

From the reveal of NBA star Dwyane Wade’s cancer surgery to a Bachelorette star on her husband’s cancer diagnosis, here is ...

Thyroid disease is often missed in older adults because its symptoms overlap with those of “normal aging.” In this ...

GLP-1RAs were not associated with an increased risk for thyroid cancer relative to DPP-4 inhibitor use among an international cohort.

Use of long-acting, reversible contraceptives is associated with an increased risk of certain cancers, a study suggests.

The ecological study determined that per- and poly-fluoroalkyl substances (PFAS) from drinking water through examination of the associations between PFAS in drinking water measured in two waves ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 ...